<i><scp>PRRT</scp>2</i> mutation screening in patients with paroxysmal kinesigenic dyskinesia from <scp>S</scp>outhwest <scp>C</scp>hina

Yinan Chen, Wei Song, Jun‐Li Yang, Zequn Zheng, Rui Huang, Kai Chen, Bin Zhao, X. P. Chen, Jean‐Marc Burgunder, Huifang Shang

European Journal of Neurology · 2013 · 18 citations · 19 references

Concepts

Abstract

BACKGROUND AND PURPOSE: Proline-rich transmembrane protein 2 (PRRT2) has recently been identified as a causative gene of paroxysmal kinesigenic dyskinesia (PKD). However, the frequencies of its mutations and their correlation with the clinical features of PKD remain largely unknown. METHODS: Four exons of PRRT2 in 33 patients with PKD from Southwest China were screened by direct sequencing in this study. RESULTS: The mean onset age of the patients was 12.50 ± 2.70 years. Sixteen patients (48.48%) had sensory aura before their attacks. In total, 66.67% of the patients were running when the attacks occurred. c.649_650insC (p.P217fsX7), the most commonly reported insertion mutation, was identified in nine patients (27.27%). CONCLUSIONS: Other genes are involved in the development of PKD, but PRRT2 is a common causative gene for patients with PKD from Southwest China.

References

19